Grifols | GRFS - L'Utile Operativo





L'Utile Operativo Cambiamento Data
Alaunos Therapeutics USD -952K 60K 2026-06
Arca Biopharma USD -36.43M 2M 2026-03
aTyr Pharma USD -104K 24K 2026-06
Bio Path USD -297K 191K 2026-03
Brainstorm Cell Therapeutics USD -2.05M 198K 2026-03
Capricor Therapeutics USD -29.16M 2.87M 2025-12
Cara Therapeutics USD -7.05M 1.11M 2026-03
GlaxoSmithKline GBP 2.86B 251M 2026-09
Grifols EUR 320.55M 91.01M 2025-12
Immunic USD -23.33M 2.67M 2025-12
Minerva Neurosciences USD -21.85M 17.48M 2024-12
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Sangamo BioSciences USD -33.51M 12.77M 2024-06
TherapeuticsMD USD -1.18M 40K 2024-06